Castle Biosciences (CSTL) Prepaid Assets (2018 - 2026)

Castle Biosciences has reported Prepaid Assets for 9 years, with the latest figure at $15.4 million in Q2 2026.

• Quarterly Prepaid Assets rose 27.47% year-over-year to $15.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $15.4 million (up 27.47% YoY) and the FY2025 annual result came in at $8.0 million, up 3.72% from the prior year.
• Prepaid Assets grew to $15.4 million in Q2 2026 per CSTL's latest filing, from $14.5 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $15.4 million in Q2 2026 and troughed at $5.2 million in Q1 2022.
• A 5-year average of $8.4 million and a median of $6.9 million in 2023 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2024 and 2025: Prepaid Assets retreated 8.47% in 2024, then soared 79.59% in 2025.
• Over 5 years, Prepaid Assets stood at $6.2 million in 2022, then increased by 1.37% to $6.3 million in 2023, then rose by 21.92% to $7.7 million in 2024, then increased by 3.72% to $8.0 million in 2025, then soared by 93.24% to $15.4 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $15.4 million, $14.5 million, and $8.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.